Tag: Prescription Drugs
Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis
Icotronkinra results in significantly higher incidence of complete skin clearance at week 16 than placebo
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
No significant increase in hazard ratios seen for GI events for semaglutide versus dulaglutide, tirzepatide versus dulaglutide, tirzepatide versus semaglutide
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs
HLA-B*58:01 and HLA-A*34:02 linked to increased risk, while no HLA class II alleles were identified
Dupilumab Reduces Mucus Plug Scores With Moderate-to-Severe Asthma
Dupilumab treatment also improved patients’ lung function
Reducing Use of Sleep Drugs Helps Older Adults Live Better
Benefits include reduction in falls and cognitive impairment and improvements in life expectancy, quality of life
SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D
SGLT-2 inhibitors linked lower risk for autoimmune rheumatic diseases compared with sulfonylureas
CHEST: Nerandomilast Slows Decline in FVC in Idiopathic Pulmonary Fibrosis
No significant difference seen in composite end point of acute exacerbation, hospitalization for respiratory cause, or death
Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer
15.8 percent lower risk for death seen with abemaciclib-ET versus ET in intent-to-treat population
Enzalutamide + Leuprolide Boosts Overall Survival for Prostate Cancer With High Recurrence Risk
Enzalutamide monotherapy was not superior to leuprolide alone
FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
Twice-daily oral tablet marks first approval of idiopathic pulmonary fibrosis in more than 10 years
